Please assess the completion status of the following clinical trial:

Trial Title: Paracervical Block in First Trimester Surgical Abortions

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* age greater than or equal to 18 years~* English-speaking~* ability and willingness to sign the informed consent~* ability and willingness to comply with the terms of the study~* voluntary request for pregnancy termination~* ultrasound-confirmed singleton intrauterine pregnancy with an estimated gestational age not exceeding 76 days (10 6/7 weeks) from the first day of the preceding menstrual cycle~Exclusion Criteria:~* women who require or request sedation~* untreated acute cervicitis or pelvic inflammatory disease~* contraindications to lidocaine such as allergy to lidocaine, cardiac arrhythmia or heart block, and porphyria~* allergic reaction or sensitivity to lorazepam or NSAIDs~* chronic NSAID use~* history of gastritis or gastric ulcer~* acute renal failure or chronic renal disease~* chronic liver disease~* history of bleeding diathesis~* chronic narcotic use~* current or past history of illegal drug use (excluding marijuana)

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: t

Study Arms:
- paracervical block with lidocaine (Type: ACTIVE_COMPARATOR): Subjects who receive pain control using paracervical block with lidocaine during first trimester surgical abortion
- paracervical block with ketorolac and lidocaine (Type: EXPERIMENTAL): Subjects who receive pain control using paracervical block with ketorolac and lidocaine during first trimester surgical abortion

Based on this trial design, predict the completion outcome and termination type (if applicable).